Graft Is A Survival Horror RPG From The Makers Of Shadowrun Returns and Battletech

Newly-independent developer that now goes by the name Harebrained (previously Harebrained Schemes) has revealed the new game they are working after parting ways with Paradox Interactive.

Graft is a “post-cyberpunk survival horror RPG” where the main draw is the ability to graft new body parts.

Think Elden Ring’s Godrick The Grafted being able to replace limbs, or Lego Galidor where limb-swapping (glitching) is a play feature, as you Ship Of Theseus your own self by replacing gear with better gear in the form of body parts, as you escape a dying space station.

Each time you Graft, it doesn’t just change the character’s physical form, but it also brings the grafted part’s previous owner’s consciousness. So every Graft, the character you play as is less and less themselves, which can either be seen as something horrifying or something liberating. You’ll be on a journey of self-discovery as you impart more and more grafted elements into you.

Whether you remain human by the time you escape the station or not is another question.

Graft sets the player as a survivor on the space station Arc. From the little teases of gameplay footage from the reveal trailer, expect Graft to have that top-down isometric view similar to Harebrained’s past games like the Trilogy of Shadowrun games (Shadowrun Returns, Shadowrun Dragonfall, Shadowrun Hong Kong) as well as their last game under Paradox The Lamplighters League.

Graft will have RPG elements which extends to building relationships with other survivors (or not), with fate-determining decisions available.

As for the survival horrror element, aside from the darker aesthetic, there is an element of resource management in play. No word on obtuse puzzles to solves though, so it’s not that kind of survival horror.

Graft has no release date yet, but it is set to launch on PC via Steam and the Epic Games Store.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept